作为Cbl-b抑制剂的杂环化合物
本发明涉及新杂环化合物,其作为Cbl‑b抑制剂在制造用于治疗与其相关的疾病的药物中有用。这些药物对于癌症的预防和治疗特别有用。
APPLICANTS
Browse source applicant names and unchanged name fields from imported patent records.
These are name-based results, not verified legal entities. Identical names may refer to different people or organizations; aliases and historical names are not merged.
This name was extracted from a distinct applicant node in the source XML.
1 indexed patent records
Patent counts refer to distinct records held by this site, not an applicant’s complete portfolio. A joint name field is not a single company.
Verified corpus date coverage and last import time are not currently available. Publication dates on patent records are not import dates. Cached directory results may lag behind new imports.
Search the local original applicant field containing this full text. Results may include joint lists or longer names; this is not an exact identity search.
Search patents with this applicant condition